CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China flag China · Delayed Price · Currency is CNY
32.56
-0.12 (-0.37%)
Nov 17, 2026, 1:45 PM CST

SHE:300765 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
4,5412,1581,9812,5392,6261,850
Revenue Growth
116.78%8.93%-21.98%-3.34%42.00%40.40%
Gross Profit
3,022819.96825.521,1551,133807.09
Operating Income
1,194-625.75-276.66153.8747.14434.9
Net Income
992.78-241.1353.73434.44726.28393.23
Earnings Per Share
0.71-0.170.040.310.540.29
EPS Growth
---87.65%-42.76%84.73%15.52%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '24 Dec '23 Jan '23
Other
43.3352.64--
Biopharmaceuticals
256.9387.834.7-
Inter-Segment Elimination
-0.04---
Functional Foods and Raw Materials
1,8571,8402,4502,243
Total
2,1581,9812,5392,626

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,4631,3661,6983,7702,1961,658
Total Debt
792.495.650.841.6520.020.84
Net Cash (Debt)
1,6711,3601,6973,7692,1761,657
Net Cash Growth
35.51%-19.84%-54.97%73.21%31.29%13.45%
Net Cash Per Share
1.200.981.212.701.631.24

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
2,650-195.69-1,235721.14640.72292.09
Capital Expenditures
-613.09-568.39-477.78-581.42-114.05-195.41
Free Cash Flow
2,037-764.08-1,713139.72526.6796.67
Free Cash Flow Growth
----73.47%444.79%-58.21%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
66.54%38.00%41.68%45.51%43.15%43.63%
Operating Margin
26.29%-29.00%-13.97%6.06%28.45%23.51%
Pretax Margin
26.83%-25.56%-11.17%10.33%32.41%25.84%
Profit Margin
21.86%-11.18%2.71%17.11%27.65%21.26%
FCF Margin
44.87%-35.41%-86.47%5.50%20.05%5.23%

Dividends

Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.0200.2670.0690.069
Dividend Per Share Growth
-92.50%284.29%0%94.94%
Dividend Yield
0.07%0.87%0.95%0.98%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
45.75-689.2298.6913.4521.30
Forward PE
35.72102.6851.6050.2112.60-
P/FCF Ratio
22.12--306.8518.5486.64
PS Ratio
9.9223.2818.6916.893.724.53